Alison Armour
Company: CURADH Pharmaceuticals
Job title: Founder and CMO
Seminars:
Designing the Next Generation of Molecularly Targeted Radiotherapies (MTRs) 12:00 pm
Addressing limitations with safety and efficacy in solid tumors Tailoring next generation of MTRs for their PK/PD characteristics and tumour uptake Considering treating a broader range of tumors for improved patient benefit through novel targetsRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One